{
    "organizations": [],
    "uuid": "421ef0103d9c41197cb26255c93838b593a80cc8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-aarti-drugs-approves-buybac/brief-indias-aarti-drugs-approves-buyback-of-equity-shares-idUSFWN1P30KE",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Aarti Drugs Approves Buyback Of Equity Shares",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Aarti Drugs Ltd:\n* SAYS APPROVES BUYBACK OF EQUITY SHARES * SAYS BUYBACK OF EQUITY SHARES WORTH UP TO 240.6 MILLION RUPEES Source text - bit.ly/2m7c2c3 Further company coverage:\n ",
    "published": "2018-01-08T20:35:00.000+02:00",
    "crawled": "2018-01-09T17:14:27.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "aarti",
        "drug",
        "ltd",
        "say",
        "approves",
        "buyback",
        "equity",
        "share",
        "say",
        "buyback",
        "equity",
        "share",
        "worth",
        "million",
        "rupee",
        "source",
        "text",
        "company",
        "coverage"
    ]
}